Owen Mumford has introduced a 16-gauge (16G) safety lancet for high-volume capillary blood sampling into its Unistik product range.
The new Unistik Touch 16G has one-touch activation and Comfort Zone Technology that minimises the pain of finger sampling.
The new safety lancet has been designed for healthcare professionals (HCPs) and test kit manufacturers. For HCPs who need to perform higher volume blood sampling on patients for a range of tests including blood gas, electrolytes, blood coagulation, total bilirubin and cardiac markers, it can be used in a variety of clinical settings and offers the benefit of fewer punctures for higher blood volumes.
It is also suited for at-home and point of care testing (POCT) kits, making it convenient for test kit inclusion by kit manufacturers who require reduced packaging, bulk order quantities and can benefit from its small form and simple user features.
The Unistik Touch 16G one-touch activation feature requires the user to simply press the device against the sample site. Activated automatically, the needle then retracts into the body of the device, minimising the risk of re-use, pre-analytical errors for multiplex tests, cross infection and needlestick injuries.
Jesper Jonsson, director of medical devices at Owen Mumford, said: “The Unistik Touch range was developed in-house to make sampling more comfortable for patients and easier for HCPs to successfully obtain the right amount of blood first-time. Our proven pain-minimising technology and simple one-touch activation makes it a very attractive option and the 16G lancet has been developed and priced competitively to ensure the same benefits in patient comfort can be offered within the growing at-home testing and POCT markets. This new solution for high volume blood sampling perfectly complements our portfolio so we can offer the market an even wider choice of safety lancet.”
The Unistik Touch 16G is available in a range of packaging configurations including 100ct, 200ct and bulk volumes. Further educational material has been created in collaboration with HCPs and key opinion leaders to support everyone in achieving reliable test results.